Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引：0
作者：
Bedoya Serna, Beatriz Eugenia [1 ]
机构：
[1] Corp Invest Biol, Medellin, Colombia
来源：
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词：
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I：
10.30554/archmed.19.1.2791.2019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数：12
相关论文
共 50 条
[41]   Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents [J].
Chang, Shiow-Huey ;
Eitzman, Sarah R. ;
Nahid, Payam ;
Finelli, Maria Lourdes U. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2014, 7 (02) :145-152
[42]   Advances in the diagnosis of latent tuberculosis infection in patients receiving renal replacement therapy [J].
Arias Guillen, M. ;
Palomar, R. ;
Arias, M. .
NEFROLOGIA, 2011, 31 (02) :137-141
[43]   Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy [J].
Sumner, Tom ;
Houben, Rein M. G. J. ;
Rangaka, Molebogeng X. ;
Maartens, Gary ;
Boulle, Andrew ;
Wilkinson, Robert J. ;
White, Richard G. .
AIDS, 2016, 30 (08) :1279-1286
[44]   Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study [J].
Runels, Tessa ;
Ragan, Elizabeth J. ;
Ventura, Alicia S. ;
Winter, Michael R. ;
White, Laura F. ;
Horsburgh, C. Robert ;
Samet, Jeffrey H. ;
Saitz, Richard ;
Jacobson, Karen R. .
BMJ OPEN, 2022, 12 (03)
[45]   Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings [J].
Lin, Ada W. C. ;
Lau, Susanna K. P. ;
Woo, Patrick C. Y. .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (05) :489-500
[46]   Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review [J].
Anke L. Stuurman ;
Marije Vonk Noordegraaf-Schouten ;
Femke van Kessel ;
Anouk M. Oordt-Speets ;
Andreas Sandgren ;
Marieke J. van der Werf .
BMC Infectious Diseases, 16
[47]   Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review [J].
Stuurman, Anke L. ;
Noordegraaf-Schouten, Marije Vonk ;
van Kessel, Femke ;
Oordt-Speets, Anouk M. ;
Sandgren, Andreas ;
van der Werf, Marieke J. .
BMC INFECTIOUS DISEASES, 2016, 16
[48]   Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan [J].
Kawatsu, Lisa ;
Kaneko, Noriyo ;
Imahashi, Mayumi ;
Kamada, Keisuke ;
Uchimura, Kazuhiro .
AIDS RESEARCH AND THERAPY, 2022, 19 (01)
[49]   Operational research in malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV [J].
Harries, Anthony D. ;
Zachariah, Rony ;
Chimzizi, Rhehab ;
Salaniponi, Felix ;
Gausi, Francis ;
Kanyerere, Henry ;
Schouten, Erik J. ;
Jahn, Andreas ;
Makombe, Simon D. ;
Chimbwandira, Frank M. ;
Mpunga, James .
BMC PUBLIC HEALTH, 2011, 11
[50]   Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV [J].
Jagi, Jaya Laxmi ;
Thomas, Christy ;
Gudi, Sai Krishna ;
Undela, Krishna .
AIDS, 2023, 37 (03) :455-465
12345